Conservative surgery in T3-T4 pharyngolaryngeal squamous cell carcinoma: An alternative to radiation therapy and to total laryngectomy for good responders to induction chemotherapy

Laryngoscope

Volumn 110, Issue 3, 2000, Pages 412-416

  Lecanu, Jean Baptiste ^a   Monceaux, Guy ^a   Périé, Sophie ^a   Angelard, Bruno ^a   St Guily, Jean Lacau ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

conservative surgery; induction chemotherapy; Laryngeal carcinoma; pharyngeal carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONSERVATIVE TREATMENT; HUMAN; LARYNGECTOMY; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; ORGAN PRESERVATION; PHARYNX CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LINEAR MODELS; LYMPH NODE EXCISION; NEOADJUVANT THERAPY; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT CARE PLANNING; PHARYNGEAL NEOPLASMS; PHARYNGECTOMY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0034016188     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1097/00005537-200003000-00015     Document Type: Article

References (20)

1. Al Sarraf M, Drelichman A, Peppard S, et al. Adjuvant cisplatinum and 5-fluorouracile 96-hour infusion in previously untreated epidermoid cancer of the head and neck [abstract]. Proc Am Soc Clin Oncol 1981; 22:428.
2. Taylor SG, Applebaum E, Showel JL, et al. A randomized trial of adjuvant chemotherapy in head and neck cancer. J Clin Oncol 1985; 3:672-679.
3. Kish JA, Ensley JF, Jacobs J, Weaver A, Cummings G, Al Sarraf M. A randomized trial of cisplatin (CACP) + 5-fluorouracile (5FU) infusion and CACP + 5FU bolus for recurrent and advanced squamous cell carcinoma of the head and neck. Cancer 1985; 56:2740-2744.
4. Schuller DE, Metch B, Stein DW, Mattox D, McCracken JD. Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the Southwest Oncology Group. Laryngoscope 1988; 98:1205-1211.
5. Demard F, Chauvel P, Santini J, Vallicioni J, Thyss A, Schneider M. Response to chemotherapy as justification for modification of the therapeutic strategy for pharyngolaryngeal carcinomas. Head Neck 1990; 12:225-231.
6. Ensley JF, Jacobs JR, Weaver A, et al. Correlation between response for cisplatinum-combination therapy and subsequent radiotherapy in previously untreated patient with advanced squamous cell cancers of the head and neck. Cancer 1984; 54:811-814.
7. Depondt J, Gehanno P, Martin M, et al. Neoadjuvant chemotherapy with carboplatin/5-fluorouracil in head and neck cancer. Oncology 1993; 50:23-27.
8. Pfister DG, Strong EW, Harrison L, et al. Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced but resectable head and neck cancer. J Clin Oncol 1991; 9:850-859.
9. The Department of Veterans Affairs Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 1991; 324:1685-1690.
10. Lefebvre JL, Chevalier D, Luboinski B, Kirkpatrick A, Collette L, Sahmoud T. Larynx preservation in piriform sinus cancer: result of the EORTC Phase III trial. J Natl Cancer Inst 1996; 88:890-899.
11. Richard JM, Sancho-Garnier H, Pessey JJ, et al. Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 1998; 34:224-228.
12. Brasnu D, Laccourreye O, Charbardes E, Bassot V, Menard M, Laccourreye H. Conservative surgery of the larynx as an alternative to total laryngectomy after neoadjuvant chemotherapy. Initial results [in French]. Ann Otolaryngol Chir Cervicofac 1993; 110:129-133.
13. Laccourreye O, Brasnu D, Biacabe B, Hans S, Seckin S, Weinstein G. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results. Head Neck 1998; 20 (7):595-599.
14. Laccourreye H, Lacau Saint Guily J, Brasnu D, Fabre A, Menard M. Supracricoid hemilaryngopharyngectomy: analysis of 240 cases. Ann Otol Rhinol Laryngol 1987; 96:217-221.
15. Leroux-Robert J. Horizontal supraglottic laryngectomy for the conservation of voice [in French]. Ann Otolaryngol Chir Cervicofac 1957; 74:52.
16. Piquet JJ. Subtotal and reconstructive surgery in the treatment of cancers of the larynx [in French]. Ann Otolaryngol Chir Cervicofac 1974; 91:311-320.
17. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481.
18. Bourhis J, Pignon JP, Domenge C, Designe L. Meta-analysis of chemotherapy in head and neck squamous cell carcinoma, on behalf of the MACH-NC collaborative group [abstract]. Proc Am Soc Clin Oncol 1998; 16:1486.
19. Bassot V, Brasnu D, Lacau St Guily J, et al. Induction chemotherapy in cancers of the respiratory and digestive tracts by continuous infusions combining cisplatinum (C), fluorouracil (F), bleomycin (B), or C and F [in French]. Ann Otolaryngol Chir Cervicofac 1986; 103:73-76.
20. Laccourreye O, Brasnu D, Trotoux J, Laccoureye H. Lymph node failure in epithelioma of the glottis floor treated by partial laryngeal surgery. Apropos of 432 patients [in French]. Ann Otolaryngol 1989; 106:330-337.